Pay in 4 interest-free payments of $6.08 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
The results with semaglutide alone are encouraging and suggest a potential new treatment option for a group of patients who previously had very few. The Phase II trial followed about 700 adults with biopsy-confirmed MASH and moderate to advanced liver scarring, including participants who had already developed early cirrhosis
Cons Alguns usurios podem ter expectativas diferentes quanto aos resultados esperados
Theres concern about the safety of different salt formulations, says Diana Isaacs, PharmD, BCADM, CDCES, an endocrinology clinical pharmacy specialist at the Cleveland Clinic Endocrinology and Metabolism Institute in Cleveland
Results can differ from person to person based on factors like genetics, lifestyle, and existing health
